Thursday, April 08, 2010

Leveraging Expanded Access and Named-Patient Programs: Best Practices for Small and Emerging Biotech and Pharma Companies

Date Posted: 03/31/2010
Size: 6.64MB
Length: 00:14:32
Thought Leader: Nicky Wisener, Biopharmaceutical Account Manager, Idis

In this episode, Ms. Wisener describes how expanded access and named-patient programs can help successfully meet patients' needs while addressing the unique challenges faced by smaller and emerging companies.

For more information on how you can be featured in a podcast, contact Dan Limbach at or call him at (847) 594-0157.

No comments: